Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.

Enterlein S, Schmidt KM, Schümann M, Conrad D, Krähling V, Olejnik J, Mühlberger E.

J Virol. 2009 May;83(9):4508-19. doi: 10.1128/JVI.02429-08.

2.

Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Weik M, Modrof J, Klenk HD, Becker S, Mühlberger E.

J Virol. 2002 Sep;76(17):8532-9.

3.

Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30.

Enterlein S, Volchkov V, Weik M, Kolesnikova L, Volchkova V, Klenk HD, Mühlberger E.

J Virol. 2006 Jan;80(2):1038-43.

4.

The Ebola virus genomic replication promoter is bipartite and follows the rule of six.

Weik M, Enterlein S, Schlenz K, Mühlberger E.

J Virol. 2005 Aug;79(16):10660-71.

5.

Inhibition of Marburg virus protein expression and viral release by RNA interference.

Fowler T, Bamberg S, Möller P, Klenk HD, Meyer TF, Becker S, Rudel T.

J Gen Virol. 2005 Apr;86(Pt 4):1181-8.

PMID:
15784912
6.
7.

Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus.

Pourrut X, Souris M, Towner JS, Rollin PE, Nichol ST, Gonzalez JP, Leroy E.

BMC Infect Dis. 2009 Sep 28;9:159. doi: 10.1186/1471-2334-9-159.

9.

Complete nucleotide sequences of Marburg virus genes 5 and 6 encoding VP30 and VP24 proteins.

Bukreyev AA, Belanov EF, Blinov VM, Netesov SV.

Biochem Mol Biol Int. 1995 Mar;35(3):605-13.

PMID:
7773195
10.
11.

Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells.

Shabman RS, Jabado OJ, Mire CE, Stockwell TB, Edwards M, Mahajan M, Geisbert TW, Basler CF.

MBio. 2014 Nov 4;5(6):e02011. doi: 10.1128/mBio.02011-14.

12.
13.

Ebola virus VP30 is an RNA binding protein.

John SP, Wang T, Steffen S, Longhi S, Schmaljohn CS, Jonsson CB.

J Virol. 2007 Sep;81(17):8967-76.

14.

Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association.

Hartlieb B, Muziol T, Weissenhorn W, Becker S.

Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):624-9.

15.

Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses.

Baker LE, Ellena JF, Handing KB, Derewenda U, Utepbergenov D, Engel DA, Derewenda ZS.

Acta Crystallogr D Struct Biol. 2016 Jan;72(Pt 1):49-58. doi: 10.1107/S2059798315021439.

16.
17.

Characterization of the L gene and 5' trailer region of Ebola virus.

Volchkov VE, Volchkova VA, Chepurnov AA, Blinov VM, Dolnik O, Netesov SV, Feldmann H.

J Gen Virol. 1999 Feb;80 ( Pt 2):355-62.

PMID:
10073695
19.

Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses.

Yaddanapudi K, Palacios G, Towner JS, Chen I, Sariol CA, Nichol ST, Lipkin WI.

FASEB J. 2006 Dec;20(14):2519-30.

20.

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.

Geisbert TW, Geisbert JB, Leung A, Daddario-DiCaprio KM, Hensley LE, Grolla A, Feldmann H.

J Virol. 2009 Jul;83(14):7296-304. doi: 10.1128/JVI.00561-09.

Items per page

Supplemental Content

Support Center